This announcement is a separate document:
多瑞医药：北京中伦（武汉）律师事务所关于西藏多瑞医药股份有限公司2023年第二次临时股东大会的法律意见书
Dorui Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Second Extraordinary General Meeting of Shareholders of Tibet Dorui Pharmaceutical Co., Ltd. in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.